EHA Congress 15th Anniversary - European Hematology Association
EHA Congress 15th Anniversary - European Hematology Association
EHA Congress 15th Anniversary - European Hematology Association
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
2 > <strong>EHA</strong> Newsletter May 2010<br />
The 15 th <strong>Congress</strong> of the Eur<br />
This year the annual congress of the <strong>European</strong> Hem<br />
Over the years the <strong>EHA</strong> <strong>Congress</strong> has become a<br />
the specialty. This year the 15 th <strong>Congress</strong> of <strong>EHA</strong><br />
The Scientific Program Comm ittee under the<br />
has again compiled an appealing program<br />
education sessions for scientists, clinic<br />
> An inspiring program of<br />
simultaneous oral and poster sessions<br />
has been selected from a record number<br />
of 2175 abstracts that were submitted.<br />
The six best abstracts will be presented<br />
during the Presidential Symposium on<br />
Saturday June 12. The <strong>EHA</strong>-ESH Joint<br />
Symposium on Friday June 11 focuses<br />
on communication with patients with<br />
Burkitt’s Lymphoma. In this interactive<br />
session both the difficulties for the<br />
clinician who must explain the need to<br />
commence treatment quickly and the<br />
perspective of patients are discussed.<br />
On Saturday June 12 the first Joint<br />
Symposium of the Japanese Society of<br />
<strong>Hematology</strong> (JSH) and <strong>EHA</strong> will be<br />
organized. The topic of this first combined<br />
symposium is a hematological disease<br />
that occurs relatively frequently in Japan<br />
compared to western <strong>European</strong> countries.<br />
On Saturday, a new session will take<br />
place. In collaboration with the <strong>European</strong><br />
Cancer Patient Coalition (ECPC), the<br />
<strong>EHA</strong> has organized a patient advocacy<br />
session investigating the relationship<br />
between clinicians and patients. The<br />
session is designed to shed light on the<br />
different views regarding access to clinical<br />
trials. Key views that will be included<br />
are those from of the patient, the researcher/clinician,<br />
journalists, and the<br />
pharmaceutical industry.<br />
The seventh <strong>EHA</strong>-ASH Joint Symposium<br />
will focus on the delivery of healthcare in<br />
outreach countries. The well-established